6-K: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants and Sanofi in discussions to sell a controlling stake in Opella
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.